HMG-CoA reductase inhibitors: Role in normal and malignant cells

Critical Reviews in Oncology/Hematology

Volumn 22, Issue 3, 1996, Pages 197-212

  Larsson, Olle ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOPRENOID; MEVALONIC ACID;

ANTINEOPLASTIC ACTIVITY; CHOLESTEROL SYNTHESIS; DRUG MECHANISM; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; REVIEW;

EID: 0029953888     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/1040-8428(96)00193-X     Document Type: Review

References (178)

1. Brown MS, Goldstein JL. Multivalent feedback regulation of HMG-CoA reductase: a control mechanism coordinating isoprenoid synthesis and cell growth. J Lipid Res 21:505-517, 1980.
2. Goldstein JL, Brown MS. Progress in understanding the LDL receptor and HMG-CoA reductase, two membrane proteins that regulate the plasma cholesterol. J Lipid Res 25:1450-1461, 1984.
3. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature 343:425-430, 1990.
4. Edwards PA. Biosynthesis of dolichol and related compounds. Regulation of sterol biosynthesis and isoprenylation of proteins. In: Vance DE, Vance J, eds. Biochemistry of lipids, lipoproteins and membranes. Elsevier Science Publishers BV, 1991; 383-401.
5. Endo A, Hasumi K. Biomedical aspect of HMG-CoA reductase inhibitors. Adv Enzyme Regul 27:53-64, 1989.
6. Myant NB. Cholesterol metabolism, LDL, and the LDL receptor. San Diego: Academic Press Inc., 1990; 33-84.
7. Axelson M, Larsson O, Zhang J, Shoda J, Sjövall J. Structural specificity in the suppression of HMG-CoA reductase in human fibroblasts by intermediates in bile acid biosynthesis. J Lipid Res 36:290-298, 1995.
8. Axelson M, Larsson O. Low density lipoprotein (LDL) cholesterol to 27-hydroxycholesterol in human fibroblasts. J Biol Chem 270:15102-15110, 1995.
9. Siperstein MD. Role of cholesterologenesis and isoprenoid synthesis in DNA replication and cell growth. J Lipid Res 25:1462-1468, 1984.
10. Siperstein MD, Fagan VM. Deletion of the cholesterol negative feedback system in liver tumors. Cancer Res 24:1108-1115, 1964.
11. Bricker LA, Morris HP, Siperstein MD. Loss of the cholesterol feedback system in the intact hepatoma-bearing rat. J Clin Invest 51:206-215, 1972.
12. Siperstein MD, Fagan VM, Morris HP. Further studies on the deletion of the cholesterol feedback system in hepatomas. Cancer Res 26:7-11, 1966.
13. Michell A, Pugh TD, Goldfarb S. Partial "feedback control" of b-hydroxy-b-methylglutaryl coenzyme A reductase activity in primary hepatocellular carcinomas. Cancer Res 38:4474-4477, 1978.
14. Siperstein MD. Regulation of cholesterol biosynthesis in normal and malignant cells. Curr Topics Cell Regul 2:65-100, 1970.
15. Polsky FI, Brown MS, Siperstein MD. Feedback control of cholesterol synthesis in circulating granulocytes and deletion of feedback control in a granulocytic leukemia. J Clin Invest 52:65a, 1973.
16. Azrolan NI, Coleman PS. A discoordinate increase in the cellular amount of 3-hydroxy-3-methylglutaryl-CoA reductase results in the loss of rate-limiting control over cholesterologenesis in a tumour cell-free system. Biochem J 258:421-425, 1989.
17. Cavenee WK, Johnston D, Melnykovych G. Regulation of cholesterol biosynthesis in HeLa S3G cells by serum lipoproteins: dexamethasone-mediated interference with suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Proc Natl Acad Sci USA 75:2103-2107, 1978.
18. Cutts JL, Melnykovych G. Defective utilization of cholesterol esters from low-density lipoprotein in a human acute lymphoblastic leukemia cell line. Biochim Biophys Acta 961:65-72, 1988.
19. James MJ, Kandutsch AA. Inter-relationships between dolichol and sterol synthesis in mammalian cell cultures. J Biol Chem 254:8442-8446, 1979.
20. Bradfute DL, Simoni RD. Non-sterol compounds that regulate cholesterologenesis. J Biol Chem 269:6645-6650, 1994.
21. Gibson DM, Parker RA, Stewaet CS, Evenson KJ. Short-term regulation of hydroxymethylglutaryl coenzyme A reductase by reversible phosphorylation: modulation of reductase phosphates in rat hepatocytes. Adv Enzyme Regul 20:263-283, 1982.
22. Miller SJ, Parker RA, Gibson DM. Phosphorylation and degradation of HMG-CoA reductase. Adv Enzyme Regul 28:65-77. 1989.
23. Roth M, Emmons LR, Perruchoud A, Block LH. Expressions of the low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase genes are stimulated by recombinant platelet-derived growth factor isomers. Proc Natl Acad Sci USA 88:1888-1892, 1991.
24. Habenicht AJR, Glomset JA, Ross RJ. Relationship of cholesterol and mevalonic acid to the cell cycle in smooth muscle and Swiss 3T3-cells stimulated by platelet derived growth factor. J Biol Chem 255:4134-5140, 1980.
25. Fairbanks KP, Witte LD, Goodman DS. Relationship between mevalonate and mitogenesis in human fibroblasts stimulated with platelet-derived growth factor. J Biol Chem 259:1546-1551, 1984.
26. Larsson O, Zetterberg A. Effects of 25-hydroxycholesterol, cholesterol and isoprenoid derivatives on the G1-progression in Swiss 3T3-cells. J Cell Physiol 129:94-102, 1986.
27. Larsson O, Latham C, Zickert P, Zetterberg A. Cell cycle regulation of human diploid fibroblasts: possible mechanisms of platelet-derived growth factor. J Cell Physiol 139:3477-3483, 1989.
28. Hemming FW. Biosynthesis of dolichol and related compounds. In: Porter JW, Spurgeon SL, eds. Biochemistry of isoprenoid compounds. New York: John Wiley and Sons, 1983; 305-354.
29. Rip JW, Rupar CA, Ravi K, Carroll KK. Distribution, metabolism and function of dolichol and polyprenols. Prog Lipid Res 24:269-309, 1985.
30. Ekström TJ, Chojnacki T, Dallner G. Metabolic labelling of dolichol and dolichyl phosphate in isolated hepatocytes. J Biol Chem 259:10460-10468, 1984.
31. Ekström TJ, Chojnacki T, Dallner, G. The alpha-saturation and terminal events in dolichol biosynthesis. J Biol Chem 262:4090-4097, 1987.
32. Struck DK, Lennarz WJ. The function of saccharide-lipids in synthesis of glycoproteins. In: Lennarz WJ. The Biochemistry of Glycoproteins and Proteoglycans. New York: Plenum Press, 1980; 35-84.
33. Kabakoff BD, Doyle JW, Kandutsch AA. Relationships among dolichyl phosphate, glycoprotein synthesis, and cell culture growth. Arch Biochem Biophys 276:382-389, 1990.
34. Bruenger E, Rilling HC. Prenylated proteins from kidney. Biochem Biophys Res Commun 139:209-214, 1986.
35. Thelin A, Löw P, Chojnacki T, Dallner G. Covalent binding of dolichyl phosphate to proteins in rat liver. Eur J Biochem 195:755-761, 1991.
36. Bansal N, Nyquist DA, Melnykovych G. Protein-linked isoprenoid lipids in dexamethasone-treated human lymphoid lines in culture. Biochem Cell Biol 70:489-495, 1992.
37. Valtersson C, vanDuijn G, Verkleij AJ, Chojnacki T, deKruijff B, Dallner G. The influence of dolichol, dolichol esters, and dolichyl phosphate on phospholipid polymorphism and fluidity in model membranes. J Biol Chem 260:2742-2751, 1985.
38. Knudsen MJ, Troy FA. Nuclear magnetic resonance studies of polyisoprenols in model membranes. Chem Phys Lipids 51:205-212, 1989.
39. deRopp JS, Troy FA. 2H-NMR investigation of the organization and dynamics of polyisoprenols in membranes. J Biol Chem 260:15669-15674, 1985.
40. Casey J, Threlfall DR. Formation of 3-hexaprenyl-4-hydroxy-benzoate by matrix-free mitochondrial membrane-rich preparations of yeast. Biochim Biophys Acta 530:487-502, 1978.
41. Ashby MN, Edwards PA. Elucidation of the deficiency in two yeast coenzyme Q mutants. J Biol Chem 265:13157-13164, 1990.
42. Olson RE, Rudney H. Biosynthesis of ubiquinone. Vitamins and Hormones 40:1-41, 1983.
43. Norling G, Glazek E, Nelson BD, Ernster L. Studies with ubiquinone-depleted submitochondrial particles, quantitative incorporation of small amounts of ubiquinone and its effects on the NADH and succinate oxidase activities. Eur J Biochem 47:475-480, 1974.
44. Stocker R, Bowry V, Frei B. Ubiqinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl Acad Sci USA 88:1646-1650, 1991.
45. Robins MJ, Hall RH, Roosevelt T. N6-(Δ2-isopentenyl) adenosine. A component of the transfer ribonucleic acid of yeast and of mammalian tissue, methods of isolation, and characterization. Biochemistry 6:1837-1847, 1967.
46. Peterofvsky A. The incorporation of mevalonic acid into the N6-(Δ2-isopentenyl) adenosine of transfer ribonucleic acid in Lactobacillus acidophilus. Biochemistry 7:472-481, 1968.
47. Faust JR, Brown MS, Goldstein JL. Synthesis of Δ2-isopentenyl tRNA from mevalonate in cultured fibroblasts. J Biol Chem 255:6546-6548, 1980.
48. Sinensky M, Logel J. Defective macromolecule biosynthesis and cell cycle progression in a mammalian cell starved for mevalonate. Proc Natl Acad Sci USA 82:3257-3261, 1985.
49. Grosjean HJ, deHenan S, Crothers DM. On the physical basis for ambiguity in genetic coding interactions. Proc Natl Acad Sci USA 75:610-614, 1978.
50. Faust JR, Dice JF. Evidence for isopentenyladenine modification on a cell cycle-regulated protein. J Biol Chem 266:9961-9970, 1991.
51. Schmidt RA, Schneider CJ, Glomset JA. Evidence for post-translational incorporation of a product of mevalonic acid into Swiss 3T3 cell proteins. J Biol Chem 259:10175-10180, 1984.
52. Kamiya Y, Sakurai A, Tamura S, et al. Structure of rhodotorucine A, a peptidyl factor, inducing mating tube formation in Rhodosporidium toruloides. Agric Biol Chem 43:363-369, 1979.
53. Sakagami Y, Yoshida M, Isogai A, Suzuki A. Peptidal sex hormones inducing conjugation tube formation in compatible mating-type cells of Tremella mesenterica. Science 212:1525-1527, 1981.
54. Farnsworth CC, Gelb MH, Glomset JA. Identification of geranylgeranyl-modified proteins in HeLa cells. Science 247:320-322, 1990.
55. Rilling HC, Breunger E, Epstein WW, Crain PF. Prenylated proteins, the structure of the isoprenoid group. Science 247:318-320, 1990.
56. Glomset JA, Gelb MH, Farnsworth CC. Prenylated proteins in eukaryotic cells: a new type of membrane anchor. Trends Biochem Sci 15:139-142, 1990.
57. Sinensky M, Lutz RJ. The prenylation of proteins. BioEssays 14:25-31, 1992.
58. Hancock JF, Magee AJ, Childs JE, Marshall CJ. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell 57:1167-1177, 1989.
59. Didsbury JR, Uhing RJ, Snyderman R. Isoprenylation of the low molecular mass GTP-binding proteins RAC1 and RAC2, possible role in membrane localization. Biochem Biophys Res Commun 175:804-812, 1990.
60. Winegar DA, Molina Y, Vedia L, Lapetina EG. Isoprenylation of rap2 proteins in platelets and human erythroleukemia cells. J Biol Chem 266:4381-4386, 1991.
61. Fukada Y, Takao T, Ohguro H, Yoshizawa T, Akino T, Shimonishi Y. Farnesylated g-subunit of photoreceptor G protein indispensable for GTP-binding. Nature 346:658-660, 1990.
62. Lai RK, Perez-Sala D, Canada FJ, Rando RR. The g subunit of transducin is farnesylated. Proc Natl Acad Sci USA 87:7673-7677, 1990.
63. Glenn JS, Watson JA, Havel CM, White JM. Identification of a prenylation site in delta virus large antigene. Science 256:1331-1333, 1992.
64. Deanin GG, Cutts JL, Pfeiffer JR, Oliver JM. Role of isoprenoid metabolism in IgE receptor-mediated signal transduction. J Immunol 10:3528-3535, 1991.
65. Reiss Y, Goldstein JL, Seabra MS, Casey PJ, Brown MS. Inhibition of purified p21ras farnesyl, protein transferase by Cys-A-AX tetrapeptides. Cell 62:81-88, 1991.
66. Reiss Y, Brown MS, Goldstein JL. Divalent cation and prenyl pyrophosphate specificities of the protein farnesyltransferase from rat brain, a zinc metalloenzyme. J Biol Chem 267:6403-6408, 1992.
67. Casey PJ, Thissen JA, Moomaw JF. Enzymatic modification of proteins with geranylgeranyl isoprenoid. Proc Natl Acad Sci USA 88:8631-8635, 1991.
68. Brown MS, Goldstein JL. Protein prenylation. Mad bet for rap. Nature 366:14-15, 1994.
69. Schroepfer GJ. Sterol biosynthesis. Annu Rev Biochem 50:585-621, 1981.
70. Hwang PL. Biological activities of oxygenated sterols: physiological and pathological implications. BioEssays 13:583-589, 1991.
71. Finocchiaro ET, Richardson T. Sterol oxides in foodstuffs: a review. J Food Protect 46:917-925, 1983.
72. Kandutsch AA, Heineger HJ, Chen HW. Effects of 25-hydroxycholesterol and 7-ketocholesterol, inhibitors of sterol synthesis, administered orally to mice. Biochem Biophys Acta 486:260-272, 1977.
73. Kandutsch AA, Chen HW. Inhibition of sterol synthesis in cultured mouse cells by 7a-hydroxycholesterol, 7b-hydroxycholesterol and 7-ketocholesterol. J Biol Chem 248:8408-8417, 1973.
74. Chen HW, Kandutsch AA, Waymonth C. Inhibition of cell growth by oxygenated deivatives of cholesterol. Nature 251:419-421, 1973.
75. Brown MS, Goldstein JL. Suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase and inhibition of cell growth of human fibroblasts by 7-ketocholesterol. J Biol Chem 249:7306-7314, 1974.
76. Kandutsch AA, Chen HW, Shown EP. Binding of 25-hydroxycholesterol and cholesterol to different cytoplasmic proteins. Proc Natl Acad Sci USA 74:2500-2506, 1977.
77. Kandutsch AA, Chen HW, Heiniger HJ. Biological activity of some oxygenated sterols. Science 201:498-501, 1978.
78. Saucier SE. Kandutsch AA, Gayen AK, Swahn DK, Spencer TA, Phirwa S. Oxysterol regulators of 3-hydroxy-3-methylglutaryl coenzyme A reductase in liver. Effect of dietary cholesterol. J Biol Chem 264:6863-6869, 1989.
79. Chang T-Y. In: Boyer, PD. Mammalian HMG-CoA reductase and its regulation. The Enzymes. Vol XVI. London: Academic Press Inc., 1983; 491-521.
80. Gibbons GF. The role of oxysterols in the regulation of cholesterol biosynthesis. Biochem Soc Trans 11:649-651, 1983.
81. Gupta A, Sexton RC, Rudney H. Modulation of regulatory oxysterol formation and low density lipoprotein suppression of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase by ketoconazole. A role of cytochrome P450 in the regulation of HMG-CoA reductase in rat intestinal epithelial cells. J Biol Chem 261:8348-8356, 1986.
82. Mitchell ED Jr, Avigan J. Control of phosphorylation and decarboxylation of mevalonic acid and its metabolites in cultured human fibroblasts and in rat liver in vivo. J Biol Chem 256:6170-6175, 1981.
83. Erickson SK, Matsui SM, Shrewsbury MA, Cooper AD, Gould RG. Effects of 25-hydroxycholesterol on rat hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in vivo, in perfused liver and in hepatocytes. J Biol Chem 253:4159-4164, 1978.
84. Cavenee WK, Chen HW, Kandutsch AA. Regulation of cholesterol biosynthesis in nucleated cells. J Biol Chem 256:2675-2681, 1981.
85. Edwards PA, Lemongello D, Kane J, Schechter I, Fogelman AM. Properties of purified rat hepatic HMG-CoA reductase and regulation of enzyme activity. J Biol Chem 255:3715-3725, 1980.
86. Tanaka RD, Edwards PA, Show-Fung L, Fogelman AM. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in avian myeloblasts. J Biol Chem 258:13331-13339, 1983.
87. Faust JR, Luskey KL, Chin DJ, Goldstein JL, Bown MS. Regulation of synthesis and degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by low density lipoprotein and 25-hydroxycholesterol in UT-1 cells. Proc Natl Acad Sci USA 79:5205-5209, 1982.
88. Gil G, Faust JR, Chin DJ, Goldstein JL, Brown MS. Membrane-bound domain of HMG-CoA reductase is required for sterol-enhanced degradation of the enzyme. Cell 41:249-258, 1985.
89. Luskey KL, Faust JR, Chin DJ, Brown MS, Goldstein JL. Amplification of the gene for 3-hydroxy-3-methylglutaryl coenzyme A reductase but not for the 53-kDa protein, in UT-1 cells. J Biol Chem 258:8462-8469, 1983.
90. Taylor FR, Saucier DE, Shown SE, Parish EP, Kandutsch AA. Correlation between oxysterol binding to a cytosolic binding protein and potency in the repression of hydroxymethylglutaryl coenzyme A reductase. J Biol Chem 259:12382-12387, 1984.
91. Dawson PA, Van Der Westhuyzen DR, Goldstein JL, Brown MS. Purification of oxysterol binding protein from hamster liver cytosol. J Biol Chem 264:9046-9052, 1989.
92. Dawson PA, Ridgway ND, Goldstein JL, Brown MS. cDNA cloning and expression of oxysterol-binding protein, an oligomer with a potential leucine zipper. J Biol Chem 264:16798-16803, 1989.
93. Rajavashisth TB, Taylor AK, Andalibi A, Svenson KL, Lusis AJ. Identification of a zinc finger protein that binds to the sterol regulatory element. Science 245:640-642, 1989.
94. Zhang J, Larsson O, Sjövall J. 7a-hydroxylation of 25-hydroxycholesterol and 27-hydroxycholesterol in human fibroblasts. Biochem Biophys Acta 1256:353-359, 1995.
95. Endo A, Kurdo M, Tanzawa K. Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites having hypocholesterolemic activity. FEBS Lett 72:323-326, 1976.
96. Endo A, Tsujita Y, Kuroda M, Tanzawa K. Inhibition of cholesterol synthesis in vitro and in vivo b1 M1-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Eur J Biochem 77:31-36, 1977.
97. Alberts AW, Chen J, Kuron G, et al. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci USA 77:3957-3961, 1980.
98. Endo A. Specific non-sterol inhibitors of HMG-CoA reductase. In: Preiss B, ed. Regulation of HMG-CoA reductase. New York: Academic Press, 1985; 49-78.
99. Alberts AW. Discovery, biochemistry and biology of lovastatin. Am J Cardiol 62:10J-15J, 1988.
100. Williams ML, Menom GK, Hanley KP. HMG-CoA reductase inhibitors perturb fatty acid metabolism and induce peroxisomes in keratinocytes. J Lipid Res 33:193-208, 1992.
101. Yamamota A, Sudo H, Endo A. Therapeutic effects of ML-236B in primary hypocholesterolemia. Atherosclerosis 35:259-266, 1980.
102. Tsujita Y, Kuroda M, Shimada Y, et al. Cs-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various anomal species. Biochem Biophys Acta 877:50-60, 1986.
103. Balasubramanian N, Brown PJ, Catt JD et al. A potent, tissue-selective, synthetic inhibitor of HMG-CoA reductase. J Med Chem 32:2038-2041, 1989.
104. Chin DJ, Luskey KL, Anderson RGW, Faust JR, Goldstein JL, Brown MS. Appearence of crystalloid endoplasmic reticulum in compactin-resistent Chinese hamster cells with a 500-fold elevation in 3-hydroxy-3-methylglutaryl coenzyme A reductase. Proc Natl Acad Sci USA 79:1185-1189, 1982.
105. Doyle JW, Kandutsch AA. Requirement for mevalonate in cycling cells: quantitative and temporal aspects. J Cell Physiol 137:137-140, 1988.
106. Carlberg M, Hjertman M, Wejde J, Larsson O. Mevalonate is essential for growth activation of human fibroblasts: Evidence for a critical role of protein glycosylation in the prereplicative period. Exp Cell Res 212:359-366, 1994.
107. Larsson O, Zetterberg A. Kinetics of G1-progression of 3T6- and SV-3T3-cells following treatment by 25-hydroxycholesterol. Cancer Res 46:1233-1239, 1986.
108. Zetterberg A, Larsson O, Wiman KG. What is the restriction point? Curr Opin Cell Biol 7:835-842, 1995.
109. Larsson O, Barrios C, Latham C, Ruiz J, Zetterberg A, Zickert P, Wejde J. Abolition of mevinolin-induced growth inhibition in human fibroblasts following transformation with Simian Virus 40. Cancer Res 49:5605-5610, 1989.
110. Larsson O, Wejde J. Dolichol delays G1-arrest for one cell cycle in human fibroblasts subjected to depletion of serum and mevalonate. J Cell Sci 103:1065-1072, 1992.
111. Quesney-Huneeus V, Wiley MA, Siperstein MD. Isopentenyladenine as a mediator of mevalonate-regulated DNA replication. Proc Natl Acad Sci USA 77:5842-5846, 1980.
112. Shoff SM, Grummer M, Yatvin MB, Elson CE. Concentration-dependent increase of murine P388 and B12 population doubling time by the acyclic monoterpene geraniol. Cancer Res 51:37-42, 1991.
113. Yachnin S. Mevalonic acid as an initiator of cell growth: Studies using human lymphocytes and inhibitors of endogenous mevalonate biosynthesis. Oncodev Biol Med 3:111-123, 1982.
114. Larson RA, Yachnin S. Mevalonic acid induces DNA synthesis in chronic lymphocytic leukemia cells. Blood 64:257-262, 1984.
115. Trentalance AS, Leoni MT, Mangiantini S, et al. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol synthesis and esterification during the first cell cycle of liver regeneration. Biochem Biophys Acta 794:142-151, 1984.
116. Schultz S, Nyce JW. Inhibition of protein isoprenylation and p21ras membrane association by dihydroepiandrosterone in human colonie adenocarcinoma cells in vitro. Cancer Res 51:6563-6567, 1991.
117. Langan TJ, Volpe JJ. Cell cycle specific requirement for mevalonate, but not cholesterol for DNA synthesis in glial primary cultures. J Neurochem 49:513-521, 1987.
118. Larsson O, Zetterberg A. Existence of a commitment program for mitosis in early G1 in tumour cells. Cell Prolif 28:33-43, 1995.
119. Cohen DC, Massoglia SL, Gospodarowicz D. Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in vascular endothelial cells. J Biol Chem 257:11106-11112, 1982.
120. Larsson O, Blegen H. Regulatory role of mevalonate in the growth of normal and neoplastic human mammary epithelial cells. Anticancer Res 13:1075-1080, 1993.
121. Wejde J, Carlberg M, Hjertman M, Larsson O. Isoprenoid growth regulation: identification of a mevalonate-labelled lipid inducing DNA synthesis in human breast cancer cells depleted of serum and mevalonate. J Cell Physiol 155:539-548, 1993.
122. Zetterberg A, Larsson O. Kinetic analysis of regulatory events leading to proliferation or quiescence of Swiss 3T3-cells. Proc Natl Acad Sci USA 82:5365-5369, 1985.
123. Larsson O. Cell cycle-specific growth inhibition of human breast cancer cells induced by metabolic inhibitors. Glycobiology 3:565-571, 1993.
124. Keyomarsi K, Sandoval L, Band V, Pardee AB. Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res 51:3602-3609, 1991.
125. Casey PL, Solski PA, Der CJ, Buss JE. p21ras is modified by a farnesyl isoprenoid. Proc Natl Acad Sci USA 86:8323-8327, 1989.
126. Schafer WR, Kim R, Sterne R, Thorne J, Kim S-H, Rine J. Genetic and pharmacological suppression of oncogenic mutations in RAS genes of yeast and humans. Science 245:379-385, 1989.
127. Jackson JH, Cochrane CG, Bourne JR, Solski PA, Buss JE, Der CJ. Farnesol modification of Kirsten-ras exon 4B protein is essential for transformation. Proc Natl Acad Sci USA 87:3042-3046, 1990.
128. Buss JE, Quillian A, Kato K, et al. The COOH-terminal domain of the rap1A (Krev-1) protein is isoprenylated and supports transformation by a 12-ras-rap1A chimeric protein. J Biol Chem 11:5123-5130, 1991.
129. DeClue JE, Vass WC, Papageorge AG, Lowy DR, Willumsen BM. Inhibition of cell growth is independent of ras function. Cancer Res 51:712-717, 1991.
130. Jakóbisiak M, Bruno S, Skierski JS, Darzynkiewicz Z. Cell cycle-specific effects of lovastatin. Proc Natl Acad Sci USA 88:3628-3632, 1991.
131. Maltese WA, Sheridan KM. Isoprenylated protein in cultured cells: subcellular distribution and changes related to altered morpology and growth arrest induced by mevalonate deprivation. J Cell Physiol 133:471-481, 1987.
132. Sepp-Lorenzino L, Rao S, Coleman PS. Cell-cycle-dependent, differential prenylation of proteins. Eur J Biochem 200:579-590, 1991.
133. Leonard S, Beck L, Sinensky M. Inhibition of isoprenoid biosynthesis and the post-translational modification of prop21ras. J Biol Chem 265:5157-5160, 1990.
134. Kohl NE, Mosser SD, deSolms J, et al. Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science 260:1934-1937, 1993.
135. James GL, Goldstein JL, Brown MS, et al. Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells. Science 260:1937-1946, 1993.
136. Tamanoi F. Inhibitors of farnesyltransferases. Trends Biochem Sci 18:349-353, 1993.
137. Gianelly AA, Terner C. Inhibition of cholesterol synthesis by dihydroepiandrosterone in lacting mammary gland. Endocrinology 83:1311-1315, 1968.
138. Hutchison CJ, Bridger JM, Cox LS, Kill IR. Weaving a pattern from disparate threads: lamin function nuclear assembly and DNA replication. J Cell Sci 107:3259-3269, 1994.
139. Moir RD, Montag-Lowy M, Goldman RD. Dynamic properties of nuclear lamins: Lamin B is associated with sites of DNA replication. J Cell Biol 125:1201-1212, 1994.
140. Firmbach-Kraft I, Stick R. Analysis of nuclear lamin isoprenylation in Xenopus oocytes: isoprenylation of lamin B3 recedes the uptake into the nucleus. J Cell Biol 129:17-24, 1995.
141. Hirschberg CB, Snider MD. Topography of glycosylation in the rough endoplasmic reticulum and golgi apparatus. Annu Rev Biochem 56:63-87, 1987.
142. Lennarz WJ. Protein glycosylation in the endoplasmic reticulum: current topological issues. Biochemistry 26:7205-7214, 1987.
143. Tominaga A, Takahashi T, Kikuchi Y, et al. Role of carbohydrate moiety of IL-5. Effects of tunicamycin on the glycosylation of IL-5 and the biological activity of deglycosylated IL-5. J Immunol 144:1345-1352, 1990.
144. Arakawa T, Yphantis DA, Lary JW, et al. Glycosylated and unglycosylated recombinant derived human stem cell factors are dimeric and have extensive regular secondary structures. J Biol Chem 266:18942-18948, 1991.
145. Turnay J, Olmo N, Risse G, von der Mark K, Lizarbe MA. 5-nucleotidase activity in cultured cell lines. Effect of different assay conditions and correlation with cell proliferation. In Vitro Cell Dev Biol 25:1055-1061, 1989.
146. Rosen OM, Chia GH, Fung C, Rubin CS. Tunicamycin-mediated depletion of insulin receptors in 3T3-LI adipocytes. J Cell Physiol 99:37-42, 1979.
147. Nilsen-Hamilton M, Shapiro JM, Massoglia SL, Hamilton RT. Selective stimulation by mitogens of incorporation of 35S-methionine into a family of proteins released into the medium by 3T3 cells. Cell 20:19-28, 1980.
148. Zona C, Eusebi F, Miledi R. Glycosylation is required for maintenance of functional voltage-activated channels in growing neocortical neurons of the rat. Proc R Soc Lond Biol 239:119-127, 1990.
149. Lund J, Tanaka T, Darmay G, Arata Y, Jefferis RA. Protein structural change in aglycosylated IgG correlates with loss of huFc-gamma R1 and huFc gamma binding and or activation. Mol Immunol 27:1145-1153, 1990.
150. Bharathan S, Moriarty J, Moody CE, Sherblom AP. Effect of tunicamycin on sialomucin and natural killer susceptibility of rat mammary tumor ascites cells. Cancer Res 50:5250-5256, 1990.
151. Segarini PR, Ziman JM, Kane CJ, Dasch JR. Two novel patterns of transforming growth factor beta (TGF beta) binding to cell surface proteins are dependent upon the binding of TGF-betal and indicate a mechanism of positive cooperativity. J Biol Chem 267:1048-1053, 1992.
152. Soderquist AM, Carpenter G. Glycosylation of the epidermal growth factor receptor in A-4341 cells. J Biol Chem 259:12586-12594, 1984.
153. Doyle JW, Ward-Bailey PF, Kandutsch AA. Effects of growth factors on cell cycle arrest in dolichyl phosphate-depleted cultures. J Cell Physiol 155:171-178, 1993.
154. Carlberg M, Larsson O. Stimulatory effect of PDGF on HMG-CoA reductase activity and N-linked glycosylation contributes to the increased expression of IGF-1 receptors in human fibroblasts. Exp Cell Res 223:142-148, 1996.
155. Vincent TS, Wulfert E, Merler E. Inhibition of growth factor signaling pathway by lovastatin. Biochem Biophys Res Commun 180:1284-1289, 1991.
156. Warren L, Fuhrer JP, Walborg EF Jr. Membrane glycoproteins in normal and virus-transformed cells. In: Schultz J, Block RE, eds. Membrane transformations in neoplasia. New York: Academic Press Inc., 1974; 1-28.
157. Eggens I, Eriksson LC, Chojnacki T, Dallner G, Role of dolichyl phosphate in regulation of protein glycosylation in 2-acetylaminofluorene-induced carcinogenesis in rat liver. Cancer Res 44:799-805, 1984.
158. Olsson JM, Eriksson LC, Dallner G. Lipid compositions of intracellular membranes isolated from rat liver nodules in Wistar rats. Cancer Res 51:3774-3780, 1991.
159. Adair WL, Brennan SL. The role of N-6-isopentenyl in tumor cell growth. Biochem Biophys Res Commun 137:208-214, 1986.
160. Silber JR, Galick H, Wu JM, Siperstein MS. The effect of mevalonic acid deprivation on enzymes of DNA replication in cells emerging from quiescence. Biochem J 288:883-889, 1992.
161. Barbu V, Dautry F. Mevalonate deprivation alters the induction of fos and myc by growth factors. Oncogene 5:1077-1080, 1990.
162. Hieter H, Trifilieff E, Richert JP, Beck JP, Luu B, Ourisson G. Antagonistic action of cholesterol towards the toxicity of hydroxysterols on cultured hepatoma cells. Biochem Biophys Res Commun 120:657-664, 1984.
163. Kandutsch AA, Chen HW. Consequences of blocked sterol synthesis in cultured cells: DNA synthesis and membrane composition. J Biol Chem 252:409-415, 1977.
164. Smith LL, Johnson BN. Biological activities of oxysterols. Free Rad Biol Med 7:285-332, 1989.
165. Sutherland RL, Murphy LC, Foo MS, Green MD, Whyborne AM, Krozowski ZS. High-affinity anti-estrogen binding site distinct from the estrogen receptor. Nature 288:273-275, 1980.
166. Lazier CB, Bapat BV. Antiestrogen binding sites: general and comparative properties. J Steroid Biochem 31:665-669, 1988.
167. Hwang PLH. High-affinity binding sites for oxygenated sterols in rat liver microsomes: possible identity with antiestrogen binding sites. Biochim Biophys Acta 1033:154-161, 1990.
168. Fargin A, Bayard F, Faye JC, et al. Further evidence for a biological role of antiestrogen-binding sites in mediating the growth inhibitory action of diphenylmetane derivatives. Chem-Biol Interact 66:101-109, 1988.
169. Tang BL, Teo CC, Sim KY, Ng ML, Kon OL. Cytostatic effect of antiestrogens in lymphoid cells: relationship to high affinity antiestrogen binding sites and cholesterol. Biochim Biophys Acta 1014:162-172, 1989.
170. Bansal N, Houle A, Melnykovych G. Apoptosis: mode of cell death induced in T cell leukemia by dexamethasone and other agents. FASEB J 5:211-216, 1991.
171. Bakos JT, Johnson BH, Thompson EB. Oxysterol-induced cell death in human leukemic T-cells correlates with oxysterol binding protein occupancy and is independent of glucocorticoid-induced apoptosis. J Steroid Biochem Mol Biol 46:415-426, 1993.
172. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 147:67-77, 1984.
173. Cohen JJ, Duke RC. Glucocorticoid activation of a calcium dependent endonuclease in thymocytes nuclei leads to cell death. J Immunol 132:38-42, 1984.
174. Compton MM, Cidlowski JA. Rapid in vivo effect of glucocorticoids on the integrity of rat lymphocyte genomic deoxyribonucleic acid. Endocrinology 118:38-45, 1986.
175. Christ M, Luu B, Mejia JE, Moosbrugger I, Bischoff P. Apoptosis induced by oxysterols in murine lymphoma cells and in normal thymocytes. Immunology 78:455-460, 1993.
176. Tipton CL, Leung PC, Johnson JS, Brooks RJ, Beitz DC. Cholesterol hydroperoxides inhibit calmodulin and suppress atherogenesis in rabbits. Biochem Biophys Res Commun 146:1166-1172, 1987.
177. 45Ca uptake: correlation with depressed DNA synthesis. J Cell Physiol 120:151-156, 1984.
178. Alnemri ES, Litwack G. Glucocorticoid-induced lymphocytolysis is not mediated by an induced endonuclease. J Biol Chem 264:4104-4111, 1989.